Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Recruitment status shows the study is no longer seeking participants, reflecting the current enrollment status. The record history updates to Revision: v3.6.0, superseding the prior Revision: v3.5.5 entry.
    Difference
    0.4%
    Check dated 2026-06-14T03:40:59.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The record history shows a new latest revision tag v3.5.5 was added. The previous v3.5.4 tag was removed.
    Difference
    0.1%
    Check dated 2026-06-06T23:57:55.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 is added to the Record History, and the prior entry v3.5.3 is removed, updating the visible version history to reflect the latest site maintenance release.
    Difference
    0.1%
    Check dated 2026-05-16T09:43:07.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page now shows an updated ClinicalTrials.gov revision/version number (from v3.5.2 to v3.5.3) in the footer, indicating a platform release rather than a change to the trial’s record details.
    Difference
    0.1%
    Check dated 2026-04-24T22:27:37.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:02.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed in the record history.
    Difference
    0.1%
    Check dated 2026-03-20T00:11:24.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.